ASN
INDV icon

Advisory Services Network’s Indivior Pharmaceuticals INDV Stock Holding History

Advisory Services Network’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122 Buy
+4
New +$132 ﹤0.01% 4655
2025
Q4 		– Sell
-4
Closed -$96 – 3033
2025
Q3 		$96 Buy
+4
New +$84 ﹤0.01% 4369

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Advisory Services Network's INDV Position: Q1 2026 in Review

Advisory Services Network opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 4 shares worth $122. The stake represents ﹤0.01% of the portfolio and ranks #4655 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in INDV as recently as Q3 2025.

Advisory Services Network first reported a position in INDV in Q3 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Advisory Services Network held 4 shares of Indivior Pharmaceuticals worth $122 as of Q1 2026.
  • Indivior Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4655 holding.
  • Advisory Services Network first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.